Ad is loading...
PEMGX
Price
$45.16
Change
-$0.64 (-1.40%)
Updated
Nov 15 closing price
VMFGX
Price
$465.18
Change
-$6.71 (-1.42%)
Updated
Nov 15 closing price
Ad is loading...

PEMGX vs VMFGX

Header iconPEMGX vs VMFGX Comparison
Open Charts PEMGX vs VMFGXBanner chart's image
Principal MidCap A
Price$45.16
Change-$0.64 (-1.40%)
VolumeN/A
CapitalizationN/A
Vanguard S&P Mid-Cap 400 Growth Idx I
Price$465.18
Change-$6.71 (-1.42%)
VolumeN/A
CapitalizationN/A
PEMGX vs VMFGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PEMGX vs. VMFGX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEMGX is a Buy and VMFGX is a StrongBuy.

FUNDAMENTALS
Fundamentals
PEMGX has more cash in the bank: 29.3B vs. VMFGX (1.23B). VMFGX pays higher dividends than PEMGX: VMFGX (1.05) vs PEMGX (0.00). PEMGX was incepted earlier than VMFGX: PEMGX (19 years) vs VMFGX (14 years). VMFGX is a more actively managed with annual turnover of: 48.00 vs. PEMGX (10.10). PEMGX has a lower initial minimum investment than VMFGX: PEMGX (1000) vs VMFGX (5000000). PEMGX (28.88) and VMFGX (28.59) have marching annual gain over last year. VMFGX return over 5 years is better than : 63.22 vs. PEMGX (47.78).
PEMGXVMFGXPEMGX / VMFGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years14 years-
Gain YTD22.98518.911122%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets29.3B1.23B2,390%
Annual Yield % from dividends0.001.05-
Returns for 1 year28.8828.59101%
Returns for 3 years2.407.0434%
Returns for 5 years47.7863.2276%
Returns for 10 years102.98143.9172%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RLX1.690.06
+3.68%
RLX Technology
GRAB4.73N/A
N/A
Grab Holdings Limited
BH210.00-2.16
-1.02%
Biglari Holdings
CNTX1.84-0.06
-3.16%
Context Therapeutics
XCUR2.90-0.28
-8.81%
Exicure Inc